Ftse Mib
34.465,68
-0,40%
DAX
18.680,20
-0,25%
S&P 500
5.317,96
-0,06%
NASDAQ
16.833,34
0,00%
Bitcoin
70.237,42
0,15%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Cortexyme Inc (CRTX) Cortexyme Inc (CRTX) Notizie

CRTX

Cortexyme (CRTX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CRTX
DataOraFonteTitoloSimboloCompagnia
26/05/202323:51Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CRTXCortexyme Inc
25/05/202322:26Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRTXCortexyme Inc
14/04/202322:13Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:CRTXCortexyme Inc
14/04/202322:07Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:CRTXCortexyme Inc
05/04/202323:16Edgar (US Regulatory)Securities Registration (section 12(b)) (8-a12b)NASDAQ:CRTXCortexyme Inc
31/03/202322:01Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CRTXCortexyme Inc
15/03/202322:07Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CRTXCortexyme Inc
13/02/202323:29Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CRTXCortexyme Inc
09/11/202222:26Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CRTXCortexyme Inc
18/12/200919:45PR Newswire (US)Cornerstone Therapeutics to Host Conference Call to Discuss Financial Guidance for 2010NASDAQ:CRTX
20/11/200921:40PR Newswire (US)Cornerstone Therapeutics Provides a Response to FDA Warning Letter on DeconsalNASDAQ:CRTX
16/11/200914:00PR Newswire (US)Cornerstone Therapeutics to Present at the 6th Annual Lazard Capital Markets Healthcare ConferenceNASDAQ:CRTX
13/11/200914:00PR Newswire (US)Cornerstone Therapeutics Appoints General CounselNASDAQ:CRTX
04/11/200913:00PR Newswire (US)Cornerstone Therapeutics Reports Third Quarter 2009 Financial ResultsNASDAQ:CRTX
21/10/200914:00PR Newswire (US)Cornerstone Therapeutics to Host Third Quarter 2009 Conference CallNASDAQ:CRTX
03/09/200914:01PR Newswire (US)Cornerstone Therapeutics Receives Approval to Acquire Commercial Rights to the Antibiotic Factive(R)NASDAQ:CRTX
03/09/200914:00PR Newswire (US)Cornerstone Therapeutics to Present at Two Upcoming Investor ConferencesNASDAQ:CRTX
20/07/200914:00PR Newswire (US)Cornerstone Therapeutics' David Price Named 2009 Chief Financial Officer of the Year by the Triangle Business JournalNASDAQ:CRTX
16/07/200901:04PR Newswire (US)Cornerstone Therapeutics Submits Regulatory Filing for Extended-Release Antitussive ProductNASDAQ:CRTX
08/07/200922:15PR Newswire (US)Cornerstone Therapeutics Inc. Announces Record Date and Meeting Date for Special Meeting of Stockholders for Vote with Respect tNASDAQ:CRTX
12/06/200922:35Dow Jones NewsUPDATE:FDA Updates Singulair Label For Neuropsychiatric EventsNASDAQ:CRTXCornerstone Therapeutics Inc.
12/06/200921:28Dow Jones NewsFDA: Updates Singulair Label For Neuropsychiatric EventsNASDAQ:CRTXCornerstone Therapeutics Inc.
19/05/200922:01PR Newswire (US)Cornerstone Therapeutics Announces Management ChangeNASDAQ:CRTX
07/05/200913:01PR Newswire (US)Cornerstone Therapeutics Announces $70 Million Strategic Transaction With Chiesi Farmaceutici SpANASDAQ:CRTX
07/05/200913:00PR Newswire (US)Cornerstone Therapeutics Reports First Quarter 2009 Financial ResultsNASDAQ:CRTX
27/04/200914:00PR Newswire (US)Cornerstone Therapeutics to Host First Quarter 2009 Conference CallNASDAQ:CRTX
13/01/200923:33Dow Jones NewsUPDATE: Singular, Zyflo Asthma Drug Safety Review ContinuesNASDAQ:CRTXCornerstone Therapeutics Inc.
13/01/200921:34Dow Jones NewsFDA: Singular, Zyflo Asthma Drug Safety Review ContinuesNASDAQ:CRTXCornerstone Therapeutics Inc.
05/11/200814:00PR Newswire (US)Cornerstone Therapeutics Announces New Board of DirectorsNASDAQ:CRTX
01/08/200616:00PR Newswire (US)Critical Therapeutics Files Controlled Release Formulation of ZileutonNASDAQ:CRTX
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CRTX

La tua Cronologia

BIT
UCG
Unicredit
BIT
STMMI
ST Microelectronics
BIT
ISP
Intesa Sanpaolo
BIT
STLAM
Stellantis NV
BIT
ENI
Eni
BIT
ENEL
Enel
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
SPM
Saipem
BIT
TIT
Telecom Italia
BIT
TEN
Tenaris
BIT
BPE
Bper Banca
BIT
LDO
Leonardo
BIT
RACE
Ferrari NV
BIT
G
Generali
BIT
SRG
Snam
BIT
BAMI
Banco BPM
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network